2-((4-Allyl-5-(4-(tert-butyl)phenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide

Catalog No. :
ACVKHY283
CAS No. :
539812-47-0
Molecular Formula :
C24H27ClN4OS
Molecular Weight :
455.03

IUPAC Name:2-((4-allyl-5-(4-(tert-butyl)phenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide

2-((4-Allyl-5-(4-(tert-butyl)phenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Allyl-5-(4-(tert-butyl)phenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide
IUPAC Name2-((4-allyl-5-(4-(tert-butyl)phenyl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide
Molecular FormulaC24H27ClN4OS
Molecular Weight455.03
SMILESO=C(NC1=CC=CC(Cl)=C1C)CSC2=NN=C(C3=CC=C(C(C)(C)C)C=C3)N2CC=C
InChI KeyAXYRXEQRUDJHFA-UHFFFAOYSA-N
SynonymSALOR-INT L445061-1EA;2-([4-ALLYL-5-(4-TERT-BUTYLPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)-N-(3-CHLORO-2-METHYLPHENYL)ACETAMIDE;Acetamide, N-(3-chloro-2-methylphenyl)-2-[[5-[4-(1,1-dimethylethyl)phenyl]-4-(2-propen-1-yl)-4H-1,2,4-triazol-3-yl]thio]-
CAS No.539812-47-0

Synthetic Route by SureRoute

1. ACVKHY283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  4. Then
  5. ACVKHY283 route product structure diagram
    ACVKHY283539812-47-0
Inquiry

2. ACVKHY283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZAEU048 route compound structure diagram
    ACZAEU04899585-94-1
  4. Then
  5. ACVKHY283 route product structure diagram
    ACVKHY283539812-47-0
Inquiry

Comments (0)